Advertisement
Advertisement
HRTX
Heron Therapeutics, Inc.
0.37
USDSponsored
0.00
+0.94%
Nov 10, 15:59 UTC -5
Closed
After-Market
0.37
0.00
-0.29%
Heron Therapeutics, Inc. (HRTX) Earnings
HRTX Earnings Reports
Positive Surprise Ratio
HRTX beat 21 of 43 last estimates.
49%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Heron Therapeutics, Inc. earnings per share and revenue
On Nov 09, 2026, HRTX reported earnings of -0.03 USD per share (EPS) for Q3 26, missing the estimate of -0.02 USD, resulting in a -9.09% surprise. Revenue reached 35.25 million, compared to an expected 38.25 million, with a -7.84% difference. The market reacted with a +26.48% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Ocular Therapeutix, Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.36
Actual
-$0.42
Surprise
-13.54%
Harrow, Inc. Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.22
Actual
$0.12
Surprise
-45.92%
SIGA Technologies Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-Actual
-$0.04
Surprise
-
Protara Therapeutics, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.35
Surprise
+6.17%
Minerva Neurosciences, Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.12
Actual
$1.94
Surprise
+1,629.97%
Tonix Pharmaceuticals Holding Corp.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$2.40
Actual
-$2.89
Surprise
-20.23%
Cumberland Pharmaceuticals Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-Actual
-$0.07
Surprise
-
PMV Pharmaceuticals, Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Corbus Pharmaceuticals Holdings, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.23
Actual
-$1.81
Surprise
-46.07%
Definium Therapeutics, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.56
Actual
-$0.46
Surprise
+19.06%
FAQ
What were Heron Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Heron Therapeutics, Inc. reported EPS of -$0.03, missing estimates by -9.09%, and revenue of $35.25M, -7.84% below expectations.
How did the market react to Heron Therapeutics, Inc.'s Q3 2026 earnings?
The stock price moved up 26.48%, changed from $0.29 before the earnings release to $0.37 the day after.
When is Heron Therapeutics, Inc. expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Heron Therapeutics, Inc.'s next earnings report?
Based on --
analysts, Heron Therapeutics, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.